Patricia Danzon
Publications and Insights
- Insight: Prevention pays off – so why aren’t we doing more of it?
- Publication: Analysing Global Immunisation Expenditure
- Insight: Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool
- Publication: Socio-Economic Value of Adult Immunisation Programmes
- Publication: Developing a Conceptual Framework of Healthcare System Pressure
- Insight: Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
- Publication: Capturing the Broader Value of Antibiotics
- Publication: NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
- Publication: Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism
- Insight: Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
- Publication: Navigating the Landscape of Digital Health – United Kingdom
- Insight: The Economics of Antibiotics – Part 4: What Does the Antibiotics Market of the Future Look Like?
- Insight: The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics
- Insight: The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot
- Insight: The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance
- Publication: The Value of Vaccines in Maintaining Health System Capacity in England
- Publication: Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?
- Publication: The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective
- Publication: Realising the Broader Value of Vaccines in the UK
- Publication: Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies
- Publication: The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
- Publication: Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?
- Publication: The Life Cycle of Pharmaceuticals: A Cross-National Perspective
- Publication: Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
- Publication: Trade and Price Differentials for Pharmaceuticals: Policy Options